Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site Sort ascending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort ascending Location Division Business Functional Area Date Posted
Medical Science Liaison West Bengal India International Innovative Medicines Research & Development Sep 02, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Functional Lead, Compliance Analytics and Reporting Telangana India Operations CTS Legal & Intellectual Property & Compl. Sep 18, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 04, 2024
Manager- Data Privacy Review and Remediation Telangana India Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Oct 10, 2024
End-to-End Supply Network Planning Manager Telangana India Operations Innovative Medicines Technical Operations Jul 01, 2024
Principal Scientist - Pathology Telangana India Biomedical Research Pharma Research Research & Development Sep 03, 2024
Analyst Telangana India Operations CTS Marketing May 02, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 14, 2024
Regional Business Manager Tamil Nadu India International Innovative Medicines Sales Sep 27, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Apr 16, 2024
TERRITORY BUSINESS EXECUTIVE-1 Rajasthan India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE Rajasthan India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Orissa India International Innovative Medicines Sales Sep 30, 2024
Territory Business Executive Orissa India International Innovative Medicines Sales Oct 01, 2024
Associate Director- Clinical Data Standards Mumbai (Office) India Development Innovative Medicines Research & Development Sep 13, 2024
Lead Principal CDS Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Sep 15, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Sep 09, 2024
Country ERC Head, India Mumbai (Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Oct 18, 2024
Expert GMP Auditor Mumbai (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Regional Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Sep 27, 2024
Medical Lead Oncology Mumbai (Head Office) India International Innovative Medicines Research & Development Sep 16, 2024
Zonal Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Oct 01, 2024
Senior Manager - Direct tax Mumbai (Head Office) India Finance Corporate Audit & Finance Oct 10, 2024
Risk & Assurance Manager Mumbai (Head Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
Global GMP Expert Quality Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Oct 07, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Sep 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Sep 03, 2024
Tax Specialist Mumbai (Head Office) India Finance Corporate Audit & Finance Oct 14, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Regional Business Manager Madhya Pradesh India International Innovative Medicines Sales Sep 27, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 03, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Kerala India International Innovative Medicines Sales Oct 04, 2024
Territory Business Executive Kerala India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales Oct 01, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only